Delivery Order SPE2DB24D1021-SPE2DB25FFBCE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) valued at $9,087.02. The contract, awarded on September 24, 2025, with completion targeted for September 25, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performance location, and the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $6,109.22. This non-set-aside, competitively awarded delivery order is classified as firm fixed price and is scheduled for completion by September 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this requirement under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) valued at $2,351.06. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 26, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract ceiling value of $3,433.81. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of April 25, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) valued at $1,592.16. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Adderall XR 30 mg capsules (quantity: 100s) valued at $2,232.71. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents performance at the contractor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,461.64 contract is for the supply of 4,563,731,620 units of Adderall XR 20 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,397.80. This award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, utilizes firm fixed price terms under a non-set-aside, competitively awarded contract. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBCEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $6,249.17. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 24, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively awarded this contract as a child order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and broader military healthcare supply chain operations. AmerisourceBergen Drug Corp's extensive federal contract portfolio with the DLA encompasses a wide range of pharmaceutical products, medical supplies, and specialty medications across multiple therapeutic domains, demonstrating the company's established capability to meet federal medical procurement requirements through competitive processes. The parent IDC vehicle enables flexible sourcing of critical medications and medical commodities to support military healthcare programs globally, with the DLA planning to establish additional Pharmaceutical Prime Vendor Global Program Generation V contracts involving multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/23/25 |